Efficacy observational study of candesartan cilexetil on hypertensive patients
Study identifier:NIS-CRO-ATA-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Non-interventional study on uncontrolled hypertensive patients for evaluating efficacy of candesartan cilexetil as Monotherapy or add-on therapy.
Medical condition
Primary hypertension
Phase
-
Healthy volunteers
No
Study drug
Candesartan Cilexeotil 16mg
Sex
All
Actual Enrollment
1940
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Sept 2007
Primary Completion Date: 01 Feb 2008
Study Completion Date: 01 Feb 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Mihai Isvoranu
AstraZeneca
